Academic Journal
LBA41 LEAP-005: Phase II study of lenvatinib (len) plus pembrolizumab (pembro) in patients (pts) with previously treated advanced solid tumours
| العنوان: | LBA41 LEAP-005: Phase II study of lenvatinib (len) plus pembrolizumab (pembro) in patients (pts) with previously treated advanced solid tumours |
|---|---|
| المؤلفون: | Lwin, Z., Gomez-Roca, C., Saada-Bouzid, E., Yanez, E., Muñoz, F. Longo, Im, S-A., Castanon, E., Senellart, H., Graham, D., Voss, M., Doherty, M., Lopez, J., Ghori, R., Kubiak, P., Jin, F., Norwood, K., Chung, H.C. |
| المصدر: | Annals of Oncology ; volume 31, page S1170 ; ISSN 0923-7534 |
| بيانات النشر: | Elsevier BV |
| سنة النشر: | 2020 |
| المجموعة: | ScienceDirect (Elsevier - Open Access Articles via Crossref) |
| نوع الوثيقة: | article in journal/newspaper |
| اللغة: | English |
| DOI: | 10.1016/j.annonc.2020.08.2271 |
| الاتاحة: | http://dx.doi.org/10.1016/j.annonc.2020.08.2271 https://api.elsevier.com/content/article/PII:S0923753420423531?httpAccept=text/xml https://api.elsevier.com/content/article/PII:S0923753420423531?httpAccept=text/plain |
| Rights: | https://www.elsevier.com/tdm/userlicense/1.0/ ; http://www.elsevier.com/open-access/userlicense/1.0/ |
| رقم الانضمام: | edsbas.AD4AF73B |
| قاعدة البيانات: | BASE |
| DOI: | 10.1016/j.annonc.2020.08.2271 |
|---|